| abstract |
The invention relates to compounds of the general formula to a process for their preparation and to their use as pharmaceuticals for broad-spectrum spectrum in medicine. The invention also relates to selective adenosine receptor ligands, preferably selective adenosine-A1-, adenosine-A2a- and / or adenosine-A2b-receptor ligands for the prophylaxis and / or treatment of diseases, especially cardiovascular diseases, diseases of the urogenital region, pathways, inflammatory and neuroinflammatory diseases, diabetes, particularly diabetes mellitus, neurodegenerative diseases, conditions associated with pain, cancer, as well as fibrosis and cirrhosis of the liver. |